What is the most likely cause of seizures in a scrub‑typhus patient with severe thrombocytopenia (platelet count ~20 000/µL) and elevated D‑dimer?

Cerebral Venous Sinus Thrombosis (CVST) with Hemorrhagic Transformation

In a scrub typhus patient with severe thrombocytopenia (platelet count ~20,000/µL) and markedly elevated D-dimer, the most likely cause of seizures is cerebral venous sinus thrombosis (CVST) with hemorrhagic venous infarction, representing a dual pathology of infection-induced vasculitis and prothrombotic coagulopathy.

Pathophysiologic Mechanism

Scrub typhus causes endothelial cell vasculitis through Orientia tsutsugamushi infection, creating a paradoxical prothrombotic state despite severe thrombocytopenia 1, 2. The combination of:

• Severe thrombocytopenia (<50,000/µL) indicating consumptive coagulopathy
• Markedly elevated D-dimer (likely >4,000 µg/mL based on CVST diagnostic criteria) 3
• Active infection with endothelial damage

This creates the perfect substrate for venous thrombosis. The D-dimer elevation in this context represents both active thrombosis formation AND fibrinolysis, not just inflammatory response 4, 2.

Why CVST Over Direct Meningoencephalitis

While scrub typhus meningoencephalitis commonly causes seizures 5, 6, the specific laboratory pattern here—severe thrombocytopenia with elevated D-dimer—strongly suggests a thrombotic rather than purely inflammatory mechanism:

• D-dimer >4,000 µg/mL has 40-50% positive predictive value for thrombosis in hypercoagulable states 7
• Scrub typhus-associated CVST is increasingly recognized as a distinct complication 1, 2
• The platelet count of ~20,000/µL indicates overt DIC (DIC score ≥5), which is significantly associated with severe complications 4

Clinical Algorithm for Diagnosis

Immediate actions:

1. Urgent neuroimaging - CT venogram or MR venography to identify CVST before initiating anticoagulation 3, 8

   • Look for thrombosis in superior sagittal sinus, transverse sinuses, or deep venous system
   • Hemorrhagic venous infarction may be present despite thrombocytopenia 1

2. Coagulation panel - PT, fibrinogen, repeat platelet count 9

   • Fibrinogen <1.0 g/L suggests DIC 10, 9
   • PT prolongation beyond dilutional effect confirms consumptive coagulopathy

3. Examine for eschar - Present in 35% of cases but frequently missed initially 4, 6

Treatment Priorities

The management paradox: anticoagulation despite severe thrombocytopenia

1. Immediate doxycycline 100 mg IV/PO twice daily - Treats underlying infection 1, 2

2. Therapeutic anticoagulation - Despite platelet count of 20,000/µL, if CVST confirmed 3

   • Use non-heparin anticoagulants (fondaparinux, argatroban, or DOACs) to avoid potential cross-reactivity with heparin-induced thrombocytopenia-like states 3
   • The thrombotic risk outweighs bleeding risk in confirmed CVST with elevated D-dimer

3. Platelet transfusion threshold 9:

   • Keep platelets >25 × 10⁹/L in non-bleeding patients
   • Keep platelets >50 × 10⁹/L if active bleeding or before procedures

4. Consider IVIG 1 g/kg if immune-mediated thrombocytopenia suspected 3

Critical Pitfalls to Avoid

• Do NOT delay anticoagulation waiting for platelet count to rise if CVST is confirmed—mortality from untreated CVST exceeds bleeding risk 8, 2
• Do NOT assume seizures are purely from meningoencephalitis when D-dimer is markedly elevated—this pattern demands vascular imaging 1
• Do NOT miss the eschar on initial examination—check scalp, axillae, groin, and intertriginous areas 6
• Do NOT use D-dimer alone to guide anticoagulation intensity, but values >5 mg/mL warrant aggressive thrombosis screening 7

Alternative Consideration: DIC with Hemorrhagic Stroke

If imaging shows hemorrhagic infarction WITHOUT venous thrombosis, this represents DIC with microvascular thrombosis and hemorrhagic transformation 10, 9. In this scenario:

• Focus on treating underlying infection
• Maintain fibrinogen >1.5 g/L with cryoprecipitate 9
• Prophylactic-dose anticoagulation only (not therapeutic)
• More aggressive platelet support (target >50 × 10⁹/L)

The distinction is critical: CVST requires therapeutic anticoagulation; DIC-related hemorrhage does not 3, 10.

Prognosis

With early recognition and appropriate treatment (doxycycline + anticoagulation), scrub typhus-associated CVST has favorable outcomes 1, 2. However, delayed diagnosis significantly increases mortality, particularly when complicated by septic shock and MODS, which are associated with severe thrombocytopenia and overt DIC 4.